Naiyer Rizvi, MD - The Evolving Role of Immunotherapy as a Component of Multimodal Therapy in Earlier Stages of Lung Cancer: Rationale, Current Evidence, Key Trials, and Implications for Multidisciplinary Care
PeerView Heart, Lung & Blood CME/CNE/CPE Video Podcast02/07/19 • 41 min
The Evolving Role of Immunotherapy as a Component of Multimodal Therapy in Earlier Stages of Lung Cancer: Rationale, Current Evidence, Key Trials, and Implications for Multidisciplinary Care
02/07/19 • 41 min
Generate a badge
Get a badge for your website that links back to this episode
Select type & size
<a href="https://goodpods.com/podcasts/peerview-heart-lung-and-blood-cmecnecpe-video-podcast-25504/naiyer-rizvi-md-the-evolving-role-of-immunotherapy-as-a-component-of-m-4347744"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to naiyer rizvi, md - the evolving role of immunotherapy as a component of multimodal therapy in earlier stages of lung cancer: rationale, current evidence, key trials, and implications for multidisciplinary care on goodpods" style="width: 225px" /> </a>
Copy